United Kingdom - English - VMD (Veterinary Medicines Directorate)

chemo iberica s.a - benazepril hydrochloride - film-coated tablet - cardio vascular ace inhibitor - cats, dogs

United Kingdom - English - VMD (Veterinary Medicines Directorate)

chemo iberica s.a - benazepril hydrochloride - film-coated tablet - cardio vascular ace inhibitor - dogs

Australia - English - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 45664 - embolization implant, chemotherapeutic - 2 mls of biocompatible, non-resorbable, hydrophilic microshperes in glass vial. 4 sizes of bead ranging from 100 - 900 um. note: variant not on variant list, selected size (mm) to enable submission. embolisation of vessels supplying malignant hypervascularised tumours and delivery of local, controlled, sustained doses of chemotherapeutic drugs to tumours. the drug is not supplied with the device.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

paracetamol 500mg

European Union - English - EMA (European Medicines Agency)

zoetis belgium sa - maropitant citrate - alimentary tract and metabolism - dogs; cats - tablets dogs:for the prevention of nausea induced by chemotherapy.for the prevention of vomiting induced by motion sickness.for the prevention and treatment of vomiting, in conjunction with cerenia solution for injection and in combination with other supportive measures.solution for injectiondogs:for the treatment and prevention of nausea induced by chemotherapy.for the prevention of vomiting except that induced by motion sickness.for the treatment of vomiting, in combination with other supportive measures.for the prevention of perioperative nausea and vomiting and improvement in recovery from general anaesthesia after use of the μ-opiate receptor agonist morphine.cats:for the prevention of vomiting and the reduction of nausea, except that induced by motion sickness.for the treatment of vomiting, in combination with other supportive measures.

Australia - English - Department of Health (Therapeutic Goods Administration)

boston scientific pty ltd - 45664 - embolization implant, chemotherapeutic - dc beadm1 is a hydrogel bead, which is biocompatible, hydrophilic, non resorbable, size calibrated and capable of loading and eluting doxorubicin or irinotecan prior to embolisation and then as a secondary action, elute a local, controlled and sustained dose to the tumour after embolization. the drugs are not supplied with the device. the dc bead m1 is primarily intended as an embolic agent for the treatment of malignant colorectal cancer metastasised to the liver (mcrc) and hepatocellular carcinoma (hcc).

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - docetaxel 10 mg/ml - concentrate for infusion - 20 mg/2ml - active: docetaxel 10 mg/ml excipient: citric acid ethanol nitrogen polysorbate 80 - metastatic breast cancer docetaxel sandoz is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. docetaxel sandoz in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - docetaxel 10 mg/ml - concentrate for infusion - 80 mg/8ml - active: docetaxel 10 mg/ml excipient: citric acid ethanol nitrogen polysorbate 80 - metastatic breast cancer docetaxel sandoz is indicated for the treatment of patients with locally advanced or metastatic breast cancer in whom previous chemotherapy has failed. docetaxel sandoz in combination with capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.